Gretchen A. Baltus
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
Epigenetics and DNA Methylation, Genomics and Chromatin Dynamics, Pluripotent Stem Cells Research, interferon and immune responses, T-cell and B-cell Immunology
Most-Cited Works
- → The Histone H3K79 Methyltransferase Dot1L Is Essential for Mammalian Development and Heterochromatin Structure(2008)387 cited
- → Acetylation of Sox2 Induces its Nuclear Export in Embryonic Stem Cells(2009)170 cited
- → Discovery of a Novel cGAMP Competitive Ligand of the Inactive Form of STING(2018)164 cited
- → Critical Roles of Phosphorylation and Actin Binding Motifs, but Not the Central Proline-rich Region, for Ena/Vasodilator-stimulated Phosphoprotein (VASP) Function during Cell Migration(2002)133 cited
- → cGAS-STING Pathway Does Not Promote Autoimmunity in Murine Models of SLE(2021)68 cited
- → A Positive Regulatory Role for the mSin3A-HDAC Complex in Pluripotency through Nanog and Sox2(2009)68 cited
- → Role for Med12 in Regulation of Nanog and Nanog Target Genes(2008)64 cited
- → Assessment of Clinical Activity of PD-1 Checkpoint Inhibitor Combination Therapies Reported in Clinical Trials(2020)60 cited
- → Inhibition of RORγT Skews TCRα Gene Rearrangement and Limits T Cell Repertoire Diversity(2016)58 cited
- → Inhibition of spleen tyrosine kinase attenuates IgE‐mediated airway contraction and mediator release in human precision cut lung slices(2016)25 cited